• Investor Perspective: Life Science Manufacturing & Supply Chain with Biospring's Michelle Dipp

  • Mar 1 2021
  • Length: 29 mins
  • 5.0 out of 5 stars (3 ratings)
  • Summary

  • A conversation about Life Science investment trends with Michelle Dipp, MD PhD, Co-Founder and Managing Partner at Biospring Partners.

    Show more Show less

What listeners say about Investor Perspective: Life Science Manufacturing & Supply Chain with Biospring's Michelle Dipp

Average Customer Ratings
Overall
  • 5 out of 5 stars
  • 5 Stars
    3
  • 4 Stars
    0
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0
Performance
  • 5 out of 5 stars
  • 5 Stars
    3
  • 4 Stars
    0
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0
Story
  • 5 out of 5 stars
  • 5 Stars
    3
  • 4 Stars
    0
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0

Reviews - Please select the tabs below to change the source of reviews.

Sort by:
Filter by:
  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

Small Players R&D + Machine Learning

As a chemist who worked in both the academe and industry, I total agree with Dr. Dipp on how a science background can definitely help in investing and in my experience, it can basically help in anything. The main scientific method alone, and the reliance on empirical data, and running statistical models alone has helped me in work. I have transitioned into IT to Web Technologies to Digital Marketing and now with Data Science. But the main thing I wanted to comment on was on the topic of institutional memory. I totally agree that large companies can do things some things very well, small more agile companies can also do some things very well that the giants can be more of a challenge. And as mentioned, smaller companies are typically good with R&D. Now machine learning these days, is typically used to do analysis of various factors that can be done at a very large scale with multiple factors considered. But this is more of looking at existing data with known KPIs. Machine learning can also be used for R&D, for exploratory analysis. Just throwing data into machine learning, looking at various factors where correlations may not seem initially apparent, but machine learning may help see things you may not see right away. Smaller companies may lack some manpower to get things done, but because of the flexibility and the lower cost of using machine learning compared to how this was years ago, can totally be taken advantaged of. This way I would not be surprised if more and more smaller companies may find new discoveries that larger players may not find right away. However, the next step after this discovery may be the real challenge where the large players have larger capital backing to get things off the ground quicker.

  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

Wow - Learned So Much About Investing!

I loved this podcast featuring Michelle Dipp. I love her take on being from El Paso. I'm from San Diego and I agree that border towns that are also military towns are the best! We have welcoming attitudes due to our constant flow of people in and out of our community, for important reasons! Not only did I feel like I got to know Michelle Dipp in this investor interview, I got an idea how investors in the field work. It's so crazy that they follow companies for many years before deciding to invest in them. That sounds like a lot of research, and helps make sense why she's been so successful as a leader in the life science investment community. I recommend this podcast.

  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

Thought Provoking & Insightful

I really enjoyed listening to this podcast. I really enjoy seeing female STEM leaders share their thoughts and Michelle had so many great thoughts. I really enjoyed hearing Michelle Dipp's perspective on automation opportunities in healthcare and the thoughts around how companies like Illumina have helped push the capabilities and scale of genomic testing. Michelle Dipp also shared some though provoking ideas about synthetic biology. The future of science and technology are so fascinating. Thank you for sharing this podcast with Michelle Dipp, she was fantastic!